ICD-10-CM Code for Newborn affected by maternal antineoplastic chemotherapy P04.11

ICD-10 code P04.11 for Newborn affected by maternal antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Certain conditions originating in the perinatal period .

Image 2
Newborn affected by maternal antineoplastic chemotherapy

P04.1

Excludes1: dysmorphism due to warfarin (Q86.2)
fetal hydantoin syndrome (Q86.1)

Excludes2: maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
maternal use of drugs of addiction (P04.4-)

Code first , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

P04

Includes: nonteratogenic effects of substances transmitted via placenta

Excludes2: congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)

Code first any current condition in newborn, if applicable

Tabs
Get crucial instructions for accurate ICD-10-CM P04.11 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.
This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code.

Forum

Have a question about ICD-10-CM Code P04.11 ? Start a discussion here